Skip to main content

Articles

Page 5 of 11

  1. The novel coronavirus disease 2019 (COVID-19) pandemic is a global challenge. Improving public awareness about preventive measures and disseminating appropriate information about COVID-19 has a critical role i...

    Authors: Ruwidah Bonyan, Aseel Fuad Al-Karasneh, Faris El-Dahiyat and Ammar Abdulrahman Jairoun
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:43
  2. The latest outbreak of Covid-19 pandemic has placed a significant effect on health care system around the world. This article discusses the role of pharmacists in Saudi Arabia during the current Covid-19 pande...

    Authors: Ajaz Ahmad, Khalid M. Alkharfy, Ziyad Alrabiah and Abdulaziz Alhossan
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:41
  3. Pharmacies in Europe have undergone considerable changes in their regulation over the last decades, also regarding nonprescription medicines (NPMs). In 2001, selected NPMs were released for sale outside pharma...

    Authors: Solveig Nordahl Jacobsen, Simone Eggert Møller-Jensen and Sofia Kälvemark Sporrong
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:29
  4. The response to emergency public health challenges such as HIV, TB, and malaria has been successful in mobilising resources and scaling up treatment for communicable diseases. However, many of the remaining ch...

    Authors: Tamara Hafner, Marlon Banda, Jillian Kohler, Zaheer-Ud-Din Babar, Murray Lumpkin, Mojisola Christianah Adeyeye, Emmanuel Nfor, Francis Aboagye-Nyame and Javier Guzman
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:38
  5. Experiential education is a core element in developing the ability of pharmacy students to apply theory to practice, solve problems, and acquire standard pharmacist competencies. To achieve this goal, precepto...

    Authors: Abeer Zeitoun, Hala Sacre, Souheil Hallit, Rony M. Zeenny, Georges Sili and Pascale Salameh
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:21
  6. In the fight against COVID-19, frontline health workers have been vital to keeping the pandemic at bay, but recognition of individual professions’ efforts have been inconsistent at all levels. Pharmacists arou...

    Authors: Ali Elbeddini, Thulasika Prabaharan, Sarah Almasalkhi and Cindy Tran
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:36
  7. In Malaysia, for more than a decade, dipeptidyl peptidase-4 inhibitors (DPP-4i) are among the oral antidiabetic medications used as monotherapy or in combination to manage type II diabetes mellitus (T2DM). The...

    Authors: Woh Yon Mak, Jivanraj R. Nagarajah, Hannah Abdul Halim, Anitha Ramadas, Zulsairi Mohd Pauzi, Lay Ting Pee and Nirmala Jagan
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:34
  8. SARS-CoV2 is dramatically impacting the global population. Worldwide, pharmacists are changing their roles and being increasingly recognized for their role as essential service providers. This commentary provi...

    Authors: Filipa Alves da Costa, Vivian Lee, Silvana Nair Leite, Maria Dolores Murillo, Tom Menge and Sotiris Antoniou
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:12
  9. Data regarding prolonged length of hospital stay (PLOS) and in-hospital mortality are paramount to evaluate efficiency and quality of surgical care as well as for rational resource utilization, allocation, and...

    Authors: Gosaye Mekonen Tefera, Beshadu Bedada Feyisa, Gurmu Tesfaye Umeta and Tsegaye Melaku Kebede
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:24
  10. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Ali Elbeddini, Aniko Yeats and Stephanie Lee
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:30

    The original article was published in Journal of Pharmaceutical Policy and Practice 2020 13:18

  11. In 2015, the drive-through pharmacy was first introduced in Queen Elizabeth Hospital (QEH), Malaysia as one of the pharmacy value-added services. Therefore, it is imperative to review the service for further a...

    Authors: Jerry Ee Siung Liew, Aizan Adifarhan bin Abdul Gapar and Lik Ting Shim
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:27
  12. Access to safe, effective, quality and affordable essential medicines for all is a central component of Universal Health Coverage (UHC). However, the availability of quality medicines in peripheral healthcare ...

    Authors: August Kuwawenaruwa, Fabrizio Tediosi, Brigit Obrist, Emmy Metta, Fiona Chiluda, Karin Wiedenmayer and Kaspar Wyss
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:25
  13. Antibiotic resistance poses a great threat to global health, especially in low- and middle-income countries with a high infectious disease burden and limited resources. In spite of regulations, antibiotics are...

    Authors: Mohammad Abdul Matin, Wasif Ali Khan, Mohammad Mahbubul Karim, Sabeena Ahmed, Johannes John-Langba, Osman A. Sankoh, Margaret Gyapong, John Kinsman and Heiman Wertheim
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:20
  14. The coronavirus disease (COVID-19) pandemic has placed enormous pressures on the Canadian healthcare system. Patients are expected to stay home in order to contain the spread of the virus, but understandably h...

    Authors: Ali Elbeddini and Aniko Yeats
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:23
  15. The affordability of essential medicines is a challenge in achieving Universal Health Coverage (UHC). One of The Lancet Commission’s recommendations on financing of essential medicines is to ensure governments...

    Authors: Velisha Ann Perumal-Pillay and Fatima Suleman
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:17
  16. Amid COVID-19 Crisis, reporting adverse drug reactions (ADRs) and medical device incidents (MDIs) to Health Canada or health authorities in every country is crucial for monitoring medication safety and improving ...

    Authors: Ali Elbeddini, Aniko Yeats and Stephanie Lee
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:18

    The Correction to this article has been published in Journal of Pharmaceutical Policy and Practice 2020 13:30

  17. This commentary aims to elaborate challenges in the regulatory approaches for accessing and investigating COVID-19 potential therapies either with off-label use, compassionate use, emergency use or for clinica...

    Authors: Vesa Halimi, Armond Daci, Simona Stojanovska, Irina Panovska-Stavridis, Milena Stevanovic, Venko Filipce and Aleksandra Grozdanova
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:16
  18. There is plenty of evidence to support that women leaders are needed in the health and pharmaceutical sectors, although most of the leadership positions in global health are predominantly occupied by men. This...

    Authors: Nadia Bukhari, Mehr Manzoor, Huma Rasheed, Bismah Nayyer, Madeeha Malik and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:15
  19. The use of quality injectable oxytocin effectively prevents and treats postpartum hemorrhage, the leading cause of maternal death worldwide. In low- and middle-income countries (LMICs), characteristics of oxyt...

    Authors: Peter Lambert, Michelle P McIntosh, Mariana Widmer, Lawrence Evans, Megan Rauscher, Rutendo Kuwana, Fiona Theunissen, Beth Yeager and Helen Petach
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:14
  20. The world currently faces unprecedented health challenges as COVID-19 poses a huge threat to health systems, economies and societies as we know it. The events of the current COVID-19 pandemic have further emph...

    Authors: Amy Hai Yan Chan, Victoria Rutter, Diane Ashiru-Oredope, Chloe Tuck and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:13
  21. Poor job satisfaction has been associated with less productivity and high staff turnover. Various factors are thought to contribute for job dissatisfaction among pharmacy professionals and very limited studies...

    Authors: Yohanes Ayele, Behailu Hawulte, Tilayie Feto, G. Vijai Basker and Yadeta Dessie Bacha
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:11
  22. Substandard and falsified medicines, mainly prevalent in low and middle-income countries (LMICs), cause avoidable morbidity and mortality, and put at stake the performance of health systems. They may be preven...

    Authors: B. Schiavetti, E. Wynendaele, V. Melotte, J. Van der Elst, B. De Spiegeleer and R. Ravinetto
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:9
  23. Antimicrobial resistance (AMR) is an imminent threat to modern medicine. As the efficacy of treatment regimens is reduced, mortality and morbidity attributed to infectious diseases is expected to rise dramatic...

    Authors: Lyduine Nisabwe, Hirwa Brice, Marie Christine Umuhire, Olivia Gwira, Jean De Dieu Harelimana, Zephanie Nzeyimana, Osee Rurambya Sebatunzi, Emmanuel Kamanzi Rusingiza, Innocent Hahirwa and Claude Mambo Muvunyi
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:7
  24. As the lockdowns are being observed all over the globe and the national level pharmacy professionals are performing frontline roles, this editorial highlights the role of pharmacists in the COVID − 19 pandemic...

    Authors: Nadia Bukhari, Huma Rasheed, Bismah Nayyer and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:8
  25. To assess the variation in price among different brands of anticancer medicines available in hospital pharmacies at Nepalese cancer hospitals.

    Authors: Sunil Shrestha, Ramesh Sharma Poudel, Bhuvan KC, Bhupendra Kumar Poudel, Binaya Sapkota, Sabina Sharma and Anil Khadka
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:6
  26. There has been increased demand for greater public accountability and transparency of private sector-led global health partnership programs. This study critically reviews and pilot tests the World Health Organ...

    Authors: Chukwuemeka A. Umeh, Peter C. Rockers, Richard Laing, Ovi Wagh and Veronika J. Wirtz
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:5
  27. Pharmaceutical companies actively advertise their branded antibiotics, which influence their sales at community pharmacies. The major proportion of out of pocket health spending is on medicine; and affordabili...

    Authors: Pramesh Koju, Stéphane P. Rousseau, Marc Van der Putten, Archana Shrestha and Rajeev Shrestha
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:4
  28. Authors: Salman Mehmood, Syed Muhammad Farid Hasan, Chinara Maratovna Razzakova, Liliya Eugenevna Ziganshina, Azjargal Ganbat, Tsetsegmaa Sanjjav, Bruce Sunderland, Gantuya Dorj, Gereltuya Dorj, Satibi Satibi, M. Rifqi Rokhman, Hardika Aditama, Ika Kartini, Rini Ambarsari, Fajar Pramesti, Peng Yeow Loh…
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13(Suppl 1):3

    This article is part of a Supplement: Volume 13 Supplement 1

  29. Understanding why adults resort to herbal medicine can help in planning interventions aimed at increasing awareness regarding herbal use. This study sought to investigate the prevalence and to determine factor...

    Authors: Faris El-Dahiyat, Mohamed Rashrash, Sawsan Abuhamdah, Rana Abu Farha and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:2
  30. In recent years, there has been increasing pressure on public health systems in high-income countries due to high medicines prices, one of the underlying causes of which are the market monopolies granted to ph...

    Authors: Yuanqiong Hu, Dimitri Eynikel, Pascale Boulet and Gaelle Krikorian
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:1
  31. HIV in Pakistan is concentrated to people who inject drugs (PWID) and easy accessibility of narcotics to this population cannot be disregarded as a risk factor of growing encumbrance of AIDS in the country. Al...

    Authors: Tauqeer Hussain Mallhi, Yusra Habib Khan, Amjad Khan, Nasser Hadal Alotaibi, Abdulaziz Ibrahim Alzarea and Furqan Khurshid Hashmi
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:37
  32. Following publication of the original article [1], we have been notified of a few errors in the figures:

    Authors: Cristiane Mota Soares, Beatriz Nascimento, Luisa Arueira Chaves, Rondineli Mendes Silva, Maria Auxiliadora Oliveira and Vera Lucia Luiza
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:35

    The original article was published in Journal of Pharmaceutical Policy and Practice 2019 12:33

  33. Glycated hemoglobin (HbA1c) is accepted as the most reliable marker for assessing chronic glycemia. The present study aimed to investigate glycemic control in cardiovascular outcome trials (CVOTs) performed by...

    Authors: Rumiko Shimazawa and Masayuki Ikeda
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:30
  34. Medicines wastage is one of the challenges of health supply chain management in developing countries including Ethiopia. However, there is lack of objective evidence on the detailed underlying causes of medici...

    Authors: Esayas Tadesse Gebremariam, Dawit Teshome Gebregeorgise and Teferi Gedif Fenta
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:29
  35. Infertility is a major challenge for couples globally. Due to low income levels and the high cost of other assisted reproductive techniques, pharmacotherapy remain the major first line treatment option for inf...

    Authors: Stephen Mensah Arhin, Kwesi Boadu Mensah, Evans Agbeno, Vitus Sambo Badii and Charles Ansah
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:28
  36. The Kuwaiti drug regulatory authority (DRA) lack a structured classification system for the assessment of imported herbal medicines (HMs), which leads to ambiguity in the registration process. This study aimed...

    Authors: Azhar H. Alostad, Douglas T. Steinke and Ellen I. Schafheutle
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:32
  37. Quality issues in pharmaceuticals are identified as a huge global and public health problem, especially with reference to low- and middle-income countries like Pakistan. The 2011 “Fake Drug Crisis” acted as a ...

    Authors: Huma Rasheed, Ludwig Hoellein, Khalid Saeed Bukhari and Ulrike Holzgrabe
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:23
  38. Two billion people worldwide, predominantly in low- and middle-income countries, cannot consistently access required essential medications, thus affecting their ability to attain optimal health outcomes. Acces...

    Authors: Marcia McLean, Jillian Clare Kohler and Danny Edwards
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:26
  39. To identify and analyze the criteria, approaches, and conceptual frameworks, used for national/international priority setting.

    Authors: Alberto Frutos Pérez-Surio, Mercedes Gimeno-Gracia, Ma. Aránzazu Alcácera López, Ma. Asunción Sagredo Samanes, Ma. del Puerto Pardo Jario and Ma. del Tránsito Salvador Gómez
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:21
  40. To describe changes in the private market for selected originators, branded generics (‘similares’), and generic products during the 10 years following passage of the Brazilian Generics Law.

    Authors: Andréa Dâmaso Bertoldi, Anita K. Wagner, Isabel Cristina Martins Emmerick, Luisa Arueira Chaves, Peter Stephens and Dennis Ross-Degnan
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:18

Annual Journal Metrics